National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 38164 [2024-09896]
Download as PDF
<![CDATA[
38164
Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices
performance measures. HRSA
developed separate performance
measures for RCORP’s new Overdose
Response, Behavioral Health, and
Neonatal Abstinence Syndrome grants
and seeks OMB approval for the new
performance measures.
Need and Proposed Use of the
Information: Due to the growth in the
number of grant initiatives included
within RCORP, as well as emerging SUD
and other behavioral health trends in
rural communities, HRSA is submitting
a revised ICR that includes measures for
RCORP’s new Overdose Response, Child
and Adolescent Behavioral Health, and
Neonatal Abstinence Syndrome grants.
For this program, performance
measures were developed to provide
data on each RCORP initiative and to
enable HRSA to provide aggregate
program data required by Congress
under the Government Performance and
Results Act of 1993. These measures
cover the principal topic areas of
interest to HRSA’s Federal Office of
Rural Health Policy, including: (a)
provision of, and referral to, rural
behavioral health care services,
including SUD prevention, treatment
and recovery support services; (b)
behavioral health care, including SUD
prevention, treatment, and recovery,
process and outcomes; (c) education of
health care providers and community
members; (d) emerging trends in rural
behavioral health care needs and areas
of concern; and (e) consortium strength
and sustainability. All measures will
speak to the progress on meeting the set
goals of the Federal Office of Rural
Health Policy.
Likely Respondents: The respondents
will be the recipients of the RCORP
grants.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
RCORP—Implementation .....................................................................................
RCORP—Psychostimulant Support ......................................................................
RCORP—Medication Assisted Treatment Access ...............................................
RCORP—Behavioral Health Care Support ..........................................................
Rural Communities Opioid Response—Overdose Response (NEW) ..................
RCORP—Child and Adolescent Behavioral Health (NEW) ..................................
RCORP—Neonatal Abstinence Syndrome (NEW) ...............................................
290
15
11
58
47
9
41
2
1
1
1
3
2
4
580
15
11
58
141
18
164
1.24
1.30
1.95
2.02
0.56
0.48
2.31
719.20
19.50
21.45
117.16
78.96
8.64
378.84
Total ...............................................................................................................
471
..........................
987
........................
1,343.75
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–09888 Filed 5–6–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
15:55 May 06, 2024
Jkt 262001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Study
Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, Tapestry
Collection by Hilton, 8120 Wisconsin Ave,
Bethesda, MD 20814 (Hybrid Meeting).
Contact Person: Manoj Kumar
Valiyaveettil, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Drive, Room 208–R, Bethesda, MD 20817,
(301) 402–1616, manoj.valiyaveettil@nih.gov.
PO 00000
Frm 00147
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 1, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–09896 Filed 5–6–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Institute of Dental
and Craniofacial Research.
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 89, Number 89 (Tuesday, May 7, 2024)]
[Notices]
[Page 38164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09896]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Clinical and Basic Science Study Section.
Date: June 27-28, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120
Wisconsin Ave, Bethesda, MD 20814 (Hybrid Meeting).
Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 1, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-09896 Filed 5-6-24; 8:45 am]
BILLING CODE 4140-01-P
